Insight Molecular Diagnostics (IMDX) vs ENDRA Life Sciences (NDRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Insight Molecular Diagnostics is the larger company by market cap ($107.3 million vs $8.9 million), about 12.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IMDX | NDRA |
|---|---|---|
| Share price | $3.28 | $5.93 |
| Market cap | $107.34M | $8.89M |
| 1-day change | -5.20% | -2.15% |
| YTD return | -56.27% | — |
| 1-year return | -10.87% | — |
| 5-year return | -95.18% | — |
| EPS (TTM) | $-1.52 | $-6.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.51 | $9.85 |
| 52-week low | $2.42 | $2.96 |
| Distance from 52-week high | -61.46% | -39.80% |
| Analyst consensus | none | none |
| Avg. price target upside | +151.52% | +321.59% |
| Average volume | 232.87K | 34.65K |
| Shares outstanding | 32.72M | 1.50M |
| Employees | 55 | 9 |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics & Research | Diagnostics & Research |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Insight Molecular Diagnostics is about 12.1 times larger than ENDRA Life Sciences by market value ($107.34M vs $8.89M).
About Insight Molecular Diagnostics
IMDX stock →Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally.
Healthcare · Diagnostics & Research · 55 employees
About ENDRA Life Sciences
NDRA stock →ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound.
Healthcare · Diagnostics & Research · 9 employees
IMDX vs NDRA FAQ
Which is bigger, Insight Molecular Diagnostics or ENDRA Life Sciences?
Insight Molecular Diagnostics (IMDX) is larger, with a market capitalization of $107.34M compared with $8.89M for ENDRA Life Sciences (NDRA).
Are Insight Molecular Diagnostics and ENDRA Life Sciences in the same industry?
Yes. Both are classified in the Diagnostics & Research industry within the Healthcare sector.